Sector: MedicalCerus Corporation (NASDAQ: CERS)
Ranking History
Scan Date: | 3/9/2010 |
Sector: | Medical |
Funamental : | 158 |
Technical : | 123 |
Performance : | 105 |
Overall: | 97 |
Number of Stocks: | 325 |
Scan Date: | 3/2/2010 |
Sector: | Medical |
Funamental : | 150 |
Technical : | 48 |
Performance : | 69 |
Overall: | 34 |
Number of Stocks: | 326 |
Scan Date: | 2/23/2010 |
Sector: | Medical |
Funamental : | 150 |
Technical : | 61 |
Performance : | 116 |
Overall: | 62 |
Number of Stocks: | 327 |
Headlines
- Liberty Analytics Co. Initiates Independent Research Coverage on Cerus Corp.
Mar 10, 2010 09:17 AM | CERS
- Cerus to Present at Cowen and Company Annual Health Care Conference
Mar 02, 2010 08:30 AM | CERS
- Cerus Announces Fourth Quarter and Year-End 2009 Results
Feb 23, 2010 04:01 PM | CERS
- Data Presented at International Haemovigilance Seminar Confirm Safety of Cerus' INTERCEPT Blood System for Platelets and Plasma
Feb 17, 2010 08:30 AM | CERS
- Cerus to Collaborate with French National Transfusion Service on INTERCEPT Red Blood Cell Development
Feb 09, 2010 08:30 AM | CERS
- Cerus Corporation Reports Positive Outcome of Phase 1 Clinical Trial of INTERCEPT Red Blood Cells
Feb 08, 2010 08:49 PM | CERS
- Cerus to Release Fourth Quarter and Year-End 2009 Results on February 23, 2010
Feb 04, 2010 08:30 AM | CERS
- Cerus to Present at 12th Annual BIO CEO & Investor Conference
Feb 02, 2010 08:30 AM | CERS
- Cerus Corporation Reports Positive Outcome in European Study of 7-Day INTERCEPT Platelets
Jan 14, 2010 08:30 AM | CERS
- BioMed News Bytes: GeoVax, Cerus, Discovery Labs
Nov 17, 2009 04:28 PM | CERS, CRL, DSCO
- Cerus Corporation Announces Pricing of Common Stock and Warrant Offering
Aug 20, 2009 09:53 AM | CERS, COWN
- Cerus Corporation Announces Second Quarter Financial Results
Jul 30, 2009 04:05 PM | CERS
- Belgium Mandates Universal Pathogen Inactivation for Platelets
Jul 16, 2009 08:38 AM | CERS
- Cerus to Release Second Quarter Results on July 30, 2009
Jul 15, 2009 08:36 AM | CERS
- Cerus and Grifols to Collaborate on INTERCEPT Red Cell Kit Development
Jun 02, 2009 08:49 AM | CERS
- Cerus and Grifols Extend INTERCEPT Blood System Distribution to Italy
May 26, 2009 08:35 AM | CERS
- New Label Claim Expands Market for Cerus’ INTERCEPT Blood System
May 14, 2009 08:36 AM | CERS
- Cerus Corporation Announces First Quarter Financial Results
Apr 30, 2009 04:10 PM | CERS
- Cerus to Release First Quarter 2009 Financial Results on April 30, 2009
Apr 15, 2009 08:32 AM | CERS
- Cerus Announces Belgian Contract for Intercept Platelet System
Apr 14, 2009 08:43 AM | CERS
- Form 3 CERUS CORP For: Mar 02 Filed by: Hogeboom Caspar Jan (10K)
Mar 11, 2010 09:08 PM
- Form 4 CERUS CORP For: Mar 05 Filed by: CORASH LAURENCE M (10K)
Mar 09, 2010 07:06 PM
- Form 4 CERUS CORP For: Jan 14 Filed by: CORASH LAURENCE M (10K)
Jan 19, 2010 06:25 PM
- Form 4 CERUS CORP For: Jan 14 Filed by: ERVIN HOWARD G (10K)
Jan 19, 2010 06:25 PM
- Form 4 CERUS CORP For: Jan 14 Filed by: GLASSELL CLAES (10K)
Jan 19, 2010 06:24 PM
- Form 4 CERUS CORP For: Jan 14 Filed by: Greenman William Mariner (10K)
Jan 19, 2010 06:22 PM
- Form 4 CERUS CORP For: Jan 08 Filed by: CORASH LAURENCE M (10K)
Jan 12, 2010 05:54 PM
- Form 4 CERUS CORP For: Jan 06 Filed by: GLASSELL CLAES (10K)
Jan 08, 2010 09:06 PM
- Form 4 CERUS CORP For: Jan 06 Filed by: CORASH LAURENCE M (10K)
Jan 08, 2010 09:06 PM
- Form 4 CERUS CORP For: Jan 06 Filed by: ERVIN HOWARD G (10K)
Jan 08, 2010 09:05 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CERS
|
Compare to S&P
|
| YTD |
53.27 %
|
48.62 %
|
| 4 Weeks |
36.77 %
|
27.91 %
|
| 12 Weeks |
81.55 %
|
74.05 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 18.75 %
|
|
EPS Growth in Last Year: 35.00 %
|
|
Sales Growth in Last Quarter: 13.71 %
|
|
Sales Growth in Last Quarter: 50.97 %
|
|
